reference/16576485

Predicate	Object
contentType	Journal Article
endingPage	772
issn	0022-3549
issueIdentifier	4
pageRange	760-772
publicationName	Journal of Pharmaceutical Sciences
startingPage	760
bibliographicCitation	Vachharajani NN, Yeleswaram K, Boulton DW. Preclinical Pharmacokinetics and Metabolism of BMS‐214778, a Novel Melatonin Receptor Agonist. Journal of Pharmaceutical Sciences. 2003 Apr;92(4):760–72. doi: 10.1002/jps.10348.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f74ed1f030cdf0b25c046323f8c079c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7e639d7b90f1405014228b9834d348f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4f41d0f58b918c26935b915434a6089
date	200304
identifier	https://pubmed.ncbi.nlm.nih.gov/12661062 https://doi.org/10.1002/jps.10348
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5156 https://portal.issn.org/resource/ISSN/0022-3549
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Preclinical Pharmacokinetics and Metabolism of BMS‐214778, a Novel Melatonin Receptor Agonist
discusses	http://id.nlm.nih.gov/mesh/M0002710 http://id.nlm.nih.gov/mesh/M0002359 http://id.nlm.nih.gov/mesh/M0456071 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0096696
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a3d6e18d7780765d95dcf97fe10369f2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9251 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10220503 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID310265003 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128966262 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127776308

Total number of triples: 32.